Select a section from the left sidebar
Spirosta-5,25(27)-dien-1-beta,3-beta-diol-1-O-alpha-L-rhamnopyranosyl-(1→2)-alpha-L-arabinopyranoside
- Family: Plantae - Dracaenaceae
- Kingdom: Plantae
-
Class: Steroid
- Subclass: Saponin
Canonical Smiles | O[C@H]1C[C@@H](O[C@@H]2OC[C@@H](C([C@@H]2OC2O[C@@H](C)C([C@@H]([C@H]2O)O)O)O)O)[C@]2(C(=CCC3C2CC[C@]2(C3CC3C2[C@H](C)[C@]2(O3)CCC(=C)CO2)C)C1)C |
---|---|
InChI | InChI=1S/C38H58O12/c1-17-8-11-38(46-15-17)18(2)28-26(50-38)14-24-22-7-6-20-12-21(39)13-27(37(20,5)23(22)9-10-36(24,28)4)48-35-33(30(42)25(40)16-45-35)49-34-32(44)31(43)29(41)19(3)47-34/h6,18-19,21-35,39-44H,1,7-16H2,2-5H3/t18-,19-,21+,22?,23?,24?,25-,26?,27+,28?,29?,30?,31-,32+,33-,34?,35-,36-,37-,38+/m0/s1 |
InChIKey | URTQATADKAKTAX-LDYARZGJSA-N |
Formula | C38H58O12 |
HBA | 12 |
HBD | 6 |
MW | 706.87 |
Rotatable Bonds | 4 |
TPSA | 176.76 |
LogP | 1.92 |
Number Rings | 8 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Fraction CSP3 | 0.89 |
Exact Mass | 706.39 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Sansevieria trifasciata | Dracaenaceae | Plantae | 39534 |
Showing of synonyms
Spirosta-5,25(27)-dien-1-beta,3-beta-diol-1-O-alpha-L-rhamnopyranosyl-(1→2)-alpha-L-arabinopyranoside
- Tchegnitegni B, Teponno R, et al. (2015). Sappanin-type homoisoflavonoids from Sansevieria trifasciata Prain. Phytochemistry Letters, 2015, 12, 262-266. [View]
No compound-protein relationship available.
SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8
Level: 2
Mol. Weight: 706.87 g/mol
SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7
Level: 1
Mol. Weight: 706.87 g/mol
SMILES: C1OCCCC1OC2CCCCO2
Level: 1
Mol. Weight: 706.87 g/mol
SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6
Level: 0
Mol. Weight: 706.87 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 706.87 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -6.1
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -1.89
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 479.2
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.81
- Plasma Protein Binding
- 79.0
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 1.7
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -8.87
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.38
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 6.38
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -871289.25
- Rat (Acute)
- 4.11
- Rat (Chronic Oral)
- 3.73
- Fathead Minnow
- 1107.8
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 95669.76
- Hydration Free Energy
- -2.92
- Log(D) at pH=7.4
- 3.76
- Log(P)
- 3.14
- Log S
- -3.42
- Log(Vapor Pressure)
- -3050.87
- Melting Point
- 228.19
- pKa Acid
- 1.46
- pKa Basic
- 4.89